Načítá se...

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and mainly affects young adults. Its natural history has changed in recent years with the advent of disease-modifying drugs, which have been available since the early 1990s. The increasing number of first-line a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lugaresi, Alessandra, di Ioia, Maria, Travaglini, Daniela, Pietrolongo, Erika, Pucci, Eugenio, Onofrj, Marco
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699254/
https://ncbi.nlm.nih.gov/pubmed/23836975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S45144
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!